TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Seasonal Influenza Vaccines Market Report & Forecast 2022-2028

Global and United States Seasonal Influenza Vaccines Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 08 October 2022
  • Pages :104
  • Formats:
  • Report Code:SMR-7422998
OfferClick for best price

Best Price: $3480

Seasonal Influenza Vaccines Market Size, Share 2022


Market Analysis and Insights: Global Seasonal Influenza Vaccines Market

The global Seasonal Influenza Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Seasonal Influenza Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Seasonal Influenza Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Seasonal Influenza Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Seasonal Influenza Vaccines market.

Global Seasonal Influenza Vaccines Scope and Market Size

Seasonal Influenza Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Seasonal Influenza Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Seasonal Influenza Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Type A (H1N1)

Type A (H3N2)

Type B

Segment by Application

Pediatrics

Adolescence

Adults

Elderly

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

GlaxoSmithKline plc

Sinovac Biotech Ltd

Changsheng Bio-Technology

Ccbio SA

Aleph Biomedical

Sanofi

Jiangsu Simcere Vaxtec Bio-pharmaceutical

Dalian Hissen Bio-pharm

Abbott Laboratories

Novartis International AG

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Seasonal Influenza Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Seasonal Influenza Vaccines, with price, sales, revenue, and global market share of Seasonal Influenza Vaccines from 2019 to 2022.

Chapter 3, the Seasonal Influenza Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Seasonal Influenza Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Seasonal Influenza Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Seasonal Influenza Vaccines.

Chapter 13, 14, and 15, to describe Seasonal Influenza Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Seasonal Influenza Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Seasonal Influenza Vaccines Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 104 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Seasonal Influenza Vaccines Product Introduction
1.2 Global Seasonal Influenza Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Seasonal Influenza Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Seasonal Influenza Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Seasonal Influenza Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Seasonal Influenza Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Seasonal Influenza Vaccines Sales in Volume for the Year 2017-2028
1.4 Seasonal Influenza Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Seasonal Influenza Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Seasonal Influenza Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Seasonal Influenza Vaccines Market Dynamics
1.5.1 Seasonal Influenza Vaccines Industry Trends
1.5.2 Seasonal Influenza Vaccines Market Drivers
1.5.3 Seasonal Influenza Vaccines Market Challenges
1.5.4 Seasonal Influenza Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Seasonal Influenza Vaccines Market Segment by Type
2.1.1 Type A (H1N1)
2.1.2 Type A (H3N2)
2.1.3 Type B
2.2 Global Seasonal Influenza Vaccines Market Size by Type
2.2.1 Global Seasonal Influenza Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Seasonal Influenza Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Seasonal Influenza Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Seasonal Influenza Vaccines Market Size by Type
2.3.1 United States Seasonal Influenza Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Seasonal Influenza Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Seasonal Influenza Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Seasonal Influenza Vaccines Market Segment by Application
3.1.1 Pediatrics
3.1.2 Adolescence
3.1.3 Adults
3.1.4 Elderly
3.2 Global Seasonal Influenza Vaccines Market Size by Application
3.2.1 Global Seasonal Influenza Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Seasonal Influenza Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Seasonal Influenza Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Seasonal Influenza Vaccines Market Size by Application
3.3.1 United States Seasonal Influenza Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Seasonal Influenza Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Seasonal Influenza Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Seasonal Influenza Vaccines Competitor Landscape by Company
4.1 Global Seasonal Influenza Vaccines Market Size by Company
4.1.1 Top Global Seasonal Influenza Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Seasonal Influenza Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Seasonal Influenza Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Seasonal Influenza Vaccines Price by Manufacturer (2017-2022)
4.2 Global Seasonal Influenza Vaccines Concentration Ratio (CR)
4.2.1 Seasonal Influenza Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Seasonal Influenza Vaccines in 2021
4.2.3 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Seasonal Influenza Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Seasonal Influenza Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Seasonal Influenza Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Seasonal Influenza Vaccines Market Size by Company
4.5.1 Top Seasonal Influenza Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Seasonal Influenza Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Seasonal Influenza Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Seasonal Influenza Vaccines Market Size by Region
5.1 Global Seasonal Influenza Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Seasonal Influenza Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Seasonal Influenza Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Seasonal Influenza Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Seasonal Influenza Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Seasonal Influenza Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Seasonal Influenza Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Seasonal Influenza Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Seasonal Influenza Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Seasonal Influenza Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Seasonal Influenza Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Seasonal Influenza Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Seasonal Influenza Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Seasonal Influenza Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Seasonal Influenza Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Seasonal Influenza Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Seasonal Influenza Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 GlaxoSmithKline plc
7.1.1 GlaxoSmithKline plc Corporation Information
7.1.2 GlaxoSmithKline plc Description and Business Overview
7.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Products Offered
7.1.5 GlaxoSmithKline plc Recent Development
7.2 Sinovac Biotech Ltd
7.2.1 Sinovac Biotech Ltd Corporation Information
7.2.2 Sinovac Biotech Ltd Description and Business Overview
7.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Products Offered
7.2.5 Sinovac Biotech Ltd Recent Development
7.3 Changsheng Bio-Technology
7.3.1 Changsheng Bio-Technology Corporation Information
7.3.2 Changsheng Bio-Technology Description and Business Overview
7.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Products Offered
7.3.5 Changsheng Bio-Technology Recent Development
7.4 Ccbio SA
7.4.1 Ccbio SA Corporation Information
7.4.2 Ccbio SA Description and Business Overview
7.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ccbio SA Seasonal Influenza Vaccines Products Offered
7.4.5 Ccbio SA Recent Development
7.5 Aleph Biomedical
7.5.1 Aleph Biomedical Corporation Information
7.5.2 Aleph Biomedical Description and Business Overview
7.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Aleph Biomedical Seasonal Influenza Vaccines Products Offered
7.5.5 Aleph Biomedical Recent Development
7.6 Sanofi
7.6.1 Sanofi Corporation Information
7.6.2 Sanofi Description and Business Overview
7.6.3 Sanofi Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sanofi Seasonal Influenza Vaccines Products Offered
7.6.5 Sanofi Recent Development
7.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
7.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
7.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
7.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Products Offered
7.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
7.8 Dalian Hissen Bio-pharm
7.8.1 Dalian Hissen Bio-pharm Corporation Information
7.8.2 Dalian Hissen Bio-pharm Description and Business Overview
7.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Products Offered
7.8.5 Dalian Hissen Bio-pharm Recent Development
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporation Information
7.9.2 Abbott Laboratories Description and Business Overview
7.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Abbott Laboratories Seasonal Influenza Vaccines Products Offered
7.9.5 Abbott Laboratories Recent Development
7.10 Novartis International AG
7.10.1 Novartis International AG Corporation Information
7.10.2 Novartis International AG Description and Business Overview
7.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Novartis International AG Seasonal Influenza Vaccines Products Offered
7.10.5 Novartis International AG Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Seasonal Influenza Vaccines Industry Chain Analysis
8.2 Seasonal Influenza Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Seasonal Influenza Vaccines Distributors
8.3 Seasonal Influenza Vaccines Production Mode & Process
8.4 Seasonal Influenza Vaccines Sales and Marketing
8.4.1 Seasonal Influenza Vaccines Sales Channels
8.4.2 Seasonal Influenza Vaccines Distributors
8.5 Seasonal Influenza Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Seasonal Influenza Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Seasonal Influenza Vaccines Market Trends
Table 3. Seasonal Influenza Vaccines Market Drivers
Table 4. Seasonal Influenza Vaccines Market Challenges
Table 5. Seasonal Influenza Vaccines Market Restraints
Table 6. Global Seasonal Influenza Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Seasonal Influenza Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Seasonal Influenza Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Seasonal Influenza Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Seasonal Influenza Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Seasonal Influenza Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Seasonal Influenza Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Seasonal Influenza Vaccines Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Seasonal Influenza Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Seasonal Influenza Vaccines Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2021)
Table 18. Top Players of Seasonal Influenza Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Seasonal Influenza Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Seasonal Influenza Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Seasonal Influenza Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Seasonal Influenza Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Seasonal Influenza Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Seasonal Influenza Vaccines Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Seasonal Influenza Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Seasonal Influenza Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Seasonal Influenza Vaccines Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Seasonal Influenza Vaccines Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Seasonal Influenza Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Seasonal Influenza Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Seasonal Influenza Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Seasonal Influenza Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Seasonal Influenza Vaccines Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Seasonal Influenza Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Seasonal Influenza Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Seasonal Influenza Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Seasonal Influenza Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Seasonal Influenza Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Seasonal Influenza Vaccines Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Seasonal Influenza Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. GlaxoSmithKline plc Corporation Information
Table 43. GlaxoSmithKline plc Description and Business Overview
Table 44. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. GlaxoSmithKline plc Seasonal Influenza Vaccines Product
Table 46. GlaxoSmithKline plc Recent Development
Table 47. Sinovac Biotech Ltd Corporation Information
Table 48. Sinovac Biotech Ltd Description and Business Overview
Table 49. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Sinovac Biotech Ltd Product
Table 51. Sinovac Biotech Ltd Recent Development
Table 52. Changsheng Bio-Technology Corporation Information
Table 53. Changsheng Bio-Technology Description and Business Overview
Table 54. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Changsheng Bio-Technology Product
Table 56. Changsheng Bio-Technology Recent Development
Table 57. Ccbio SA Corporation Information
Table 58. Ccbio SA Description and Business Overview
Table 59. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Ccbio SA Product
Table 61. Ccbio SA Recent Development
Table 62. Aleph Biomedical Corporation Information
Table 63. Aleph Biomedical Description and Business Overview
Table 64. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Aleph Biomedical Product
Table 66. Aleph Biomedical Recent Development
Table 67. Sanofi Corporation Information
Table 68. Sanofi Description and Business Overview
Table 69. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Sanofi Product
Table 71. Sanofi Recent Development
Table 72. Jiangsu Simcere Vaxtec Bio-pharmaceutical Corporation Information
Table 73. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Business Overview
Table 74. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Jiangsu Simcere Vaxtec Bio-pharmaceutical Product
Table 76. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
Table 77. Dalian Hissen Bio-pharm Corporation Information
Table 78. Dalian Hissen Bio-pharm Description and Business Overview
Table 79. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Dalian Hissen Bio-pharm Product
Table 81. Dalian Hissen Bio-pharm Recent Development
Table 82. Abbott Laboratories Corporation Information
Table 83. Abbott Laboratories Description and Business Overview
Table 84. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Abbott Laboratories Product
Table 86. Abbott Laboratories Recent Development
Table 87. Novartis International AG Corporation Information
Table 88. Novartis International AG Description and Business Overview
Table 89. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Novartis International AG Product
Table 91. Novartis International AG Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Seasonal Influenza Vaccines Customers List
Table 95. Seasonal Influenza Vaccines Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Seasonal Influenza Vaccines Product Picture
Figure 2. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Seasonal Influenza Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Seasonal Influenza Vaccines Sales 2017-2028 (K Units)
Figure 5. United States Seasonal Influenza Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Seasonal Influenza Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Seasonal Influenza Vaccines Sales 2017-2028 (K Units)
Figure 8. United States Seasonal Influenza Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Seasonal Influenza Vaccines Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Seasonal Influenza Vaccines Report Years Considered
Figure 11. Product Picture of Type A (H1N1)
Figure 12. Product Picture of Type A (H3N2)
Figure 13. Product Picture of Type B
Figure 14. Global Seasonal Influenza Vaccines Market Share by Type in 2022 & 2028
Figure 15. Global Seasonal Influenza Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Seasonal Influenza Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Seasonal Influenza Vaccines Sales by Type (2017-2028) & (K Units)
Figure 18. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Seasonal Influenza Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 20. United States Seasonal Influenza Vaccines Market Share by Type in 2022 & 2028
Figure 21. United States Seasonal Influenza Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Seasonal Influenza Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Seasonal Influenza Vaccines Sales by Type (2017-2028) & (K Units)
Figure 24. United States Seasonal Influenza Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Seasonal Influenza Vaccines Price by Type (2017-2028) & (USD/Unit)
Figure 26. Product Picture of Pediatrics
Figure 27. Product Picture of Adolescence
Figure 28. Product Picture of Adults
Figure 29. Product Picture of Elderly
Figure 30. Global Seasonal Influenza Vaccines Market Share by Application in 2022 & 2028
Figure 31. Global Seasonal Influenza Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Seasonal Influenza Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Seasonal Influenza Vaccines Sales by Application (2017-2028) & (K Units)
Figure 34. Global Seasonal Influenza Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Seasonal Influenza Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Seasonal Influenza Vaccines Market Share by Application in 2022 & 2028
Figure 37. United States Seasonal Influenza Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Seasonal Influenza Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Seasonal Influenza Vaccines Sales by Application (2017-2028) & (K Units)
Figure 40. United States Seasonal Influenza Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Seasonal Influenza Vaccines Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Seasonal Influenza Vaccines Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Seasonal Influenza Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Seasonal Influenza Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Seasonal Influenza Vaccines Value Chain
Figure 76. Seasonal Influenza Vaccines Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount